Literature DB >> 10188592

Abnormal serum lysophospholipids in multiple myeloma patients.

T Sasagawa1, M Okita, J Murakami, T Kato, A Watanabe.   

Abstract

Lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) mediate various kinds of biological activities and play an important role in cellular signal transduction. We analyzed serum phospholipids obtained from 16 multiple myeloma (MM) patients and observed that serum LPA level was significantly higher in MM patients (5.3 +/- 0.5 nmol/mL) than in normal controls (1.7 +/- 0.3 nmol/mL). LPC level was also higher than that in normal controls, and it correlated significantly with the concentration of LPA (r = 0.678, P < 0.01). In MM patients, palmitic acid/linoleic acid ratios in phosphatidylcholine and LPC were higher than those in normal controls. In the 12-mon follow-up study of two patients with the immune globulin G type, we recognized that the increase of LPC, LPA, and arachidonic acid/linoleic acid ratio in phosphatidylinositol corresponded with a decline in the serum albumin level and choline esterase activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188592     DOI: 10.1007/s11745-999-332-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  Arachidonic acid as a second messenger. Interactions with a GTP-binding protein of human neutrophils.

Authors:  S B Abramson; J Leszczynska-Piziak; G Weissmann
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

2.  Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma.

Authors:  A Tokumura; K Harada; K Fukuzawa; H Tsukatani
Journal:  Biochim Biophys Acta       Date:  1986-01-03

3.  Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages.

Authors:  M Sakai; A Miyazaki; H Hakamata; Y Sato; T Matsumura; S Kobori; M Shichiri; S Horiuchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

4.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

5.  Potential role of phospholipase A2 in HL-60 cell differentiation to macrophages induced by protein kinase C activation.

Authors:  Y Asaoka; K Yoshida; Y Sasaki; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids. Subspecies difference.

Authors:  Y Sasaki; Y Asaoka; Y Nishizuka
Journal:  FEBS Lett       Date:  1993-03-29       Impact factor: 4.124

7.  Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.

Authors:  F Imamura; T Horai; M Mukai; K Shinkai; M Sawada; H Akedo
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

8.  Lysophosphatidic acid possesses dual action in cell proliferation.

Authors:  G Tigyi; D L Dyer; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

9.  Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.

Authors:  M Okita; D C Gaudette; G B Mills; B J Holub
Journal:  Int J Cancer       Date:  1997-03-28       Impact factor: 7.396

10.  Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages.

Authors:  J Balsinde; E A Dennis
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

View more
  29 in total

Review 1.  Phospholipase Signaling in Breast Cancer.

Authors:  Yu Jin Lee; Kyeong Jin Shin; Hyun-Jun Jang; Dong-Young Noh; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Authors:  Shannon K Oda; Pamela Strauch; Yuko Fujiwara; Amin Al-Shami; Tamas Oravecz; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

3.  Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.

Authors:  Jacinto López-Sagaseta; Leah V Sibener; Jennifer E Kung; Jenny Gumperz; Erin J Adams
Journal:  EMBO J       Date:  2012-03-06       Impact factor: 11.598

Review 4.  Role of autotaxin in cancer stem cells.

Authors:  Dongjun Lee; Dong-Soo Suh; Sue Chin Lee; Gabor J Tigyi; Jae Ho Kim
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

5.  An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples.

Authors:  Zhenwen Zhao; Yan Xu
Journal:  J Lipid Res       Date:  2009-09-25       Impact factor: 5.922

6.  Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal.

Authors:  Hironobu Yamashita; Manisha Tripathi; Jerome Jourquin; Yoonseok Kam; Shanshan Liu; Brandy Weidow; Vito Quaranta
Journal:  J Oncol       Date:  2010-08-25       Impact factor: 4.375

Review 7.  Phospholipase signalling networks in cancer.

Authors:  Jong Bae Park; Chang Sup Lee; Jin-Hyeok Jang; Jaewang Ghim; Youn-Jae Kim; Sungyoung You; Daehee Hwang; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

8.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids.

Authors:  Jurre J Kamphorst; Justin R Cross; Jing Fan; Elisa de Stanchina; Robin Mathew; Eileen P White; Craig B Thompson; Joshua D Rabinowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

9.  18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.

Authors:  Thibaut Cassou-Mounat; Sona Balogova; Valérie Nataf; Marie Calzada; Virginie Huchet; Khaldoun Kerrou; Jean-Yves Devaux; Mohamad Mohty; Jean-Noël Talbot; Laurent Garderet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-28       Impact factor: 9.236

10.  Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer.

Authors:  David H Chang; Haiteng Deng; Phillip Matthews; Joseph Krasovsky; Govind Ragupathi; Radek Spisek; Amitabha Mazumder; David H Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.